Dueling Journal Commentaries Revisit FDA Approval of Abiomed's Impella
This article was originally published in The Gray Sheet
Executive Summary
The pieces in JAMA Cardiology consider the merits of FDA's "515 Program Initiative" to classify preamendment devices and its application to a minimally invasive ventricular assist device.